Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Histone deacetylase 1 (HDAC1) |
Target Info
|
Inhibitor |
[2], [3] |
| References |
Top |
| REF 1 |
Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Clin Cancer Res. 2004 Aug 1;10(15):5271-81.
|
| REF 2 |
Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective. Anticancer Agents Med Chem. 2007 Sep;7(5):576-92.
|
| REF 3 |
Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov. 2006 Sep;5(9):769-84.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
